1. Home
  2. UG vs RNXT Comparison

UG vs RNXT Comparison

Compare UG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$7.38

Market Cap

36.5M

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$1.11

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
RNXT
Founded
1942
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5M
42.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
UG
RNXT
Price
$7.38
$1.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
9.3K
245.7K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
7.10%
N/A
EPS Growth
N/A
20.00
EPS
0.20
N/A
Revenue
$10,545,468.00
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
$36.18
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$5.58
$0.70
52 Week High
$8.78
$1.45

Technical Indicators

Market Signals
Indicator
UG
RNXT
Relative Strength Index (RSI) 47.84 71.96
Support Level $6.90 $0.82
Resistance Level $7.49 $1.28
Average True Range (ATR) 0.37 0.06
MACD -0.06 0.03
Stochastic Oscillator 21.10 91.17

Price Performance

Historical Comparison
UG
RNXT

About UG United-Guardian Inc.

United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: